How AI Is Closing the Early Detection Gap in Liver Cancer
Machine learning models trained on fusion gene biomarkers are outperforming 40 years of conventional AFP testing — and changing what’s possible in oncology screening.
The WHO Data on Liver Cancer No One Is Talking About
Global liver cancer incidence has risen 75% over the past 20 years. We break down the WHO GLOBOCAN numbers — and what they mean for high-risk patients in the US right now.